These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16284397)

  • 1. Obesity and pancreatic cancer: overall evidence and latency period.
    Michaud DS; Fuchs CS
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2678; author reply 2678-9. PubMed ID: 16284397
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of association of physical activity and obesity with incident pancreatic cancer in elderly women.
    Sinner PJ; Schmitz KH; Anderson KE; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1571-3. PubMed ID: 15941975
    [No Abstract]   [Full Text] [Related]  

  • 3. Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts.
    Larsson SC; Permert J; Håkansson N; Näslund I; Bergkvist L; Wolk A
    Br J Cancer; 2005 Nov; 93(11):1310-5. PubMed ID: 16288300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer of the pancreas. Epidemiology and risk factors].
    Robles-Díaz G; Fastag D
    Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():154-9. PubMed ID: 18277506
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pancreatic cancer linked to life style and genome].
    Sand J; Räty S; Nordback I
    Duodecim; 2009; 125(7):759-65. PubMed ID: 19432081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of obesity to pancreatic carcinogenesis.
    Gumbs AA; Bessler M; Milone L; Schrope B; Chabot J
    Surg Obes Relat Dis; 2008; 4(2):186-93. PubMed ID: 18226981
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region.
    Ansary-Moghaddam A; Huxley R; Barzi F; Lawes C; Ohkubo T; Fang X; Jee SH; Woodward M;
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2435-40. PubMed ID: 17164367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic cancer and factors associated with the insulin resistance syndrome in the Korean cancer prevention study.
    Berrington de Gonzalez A; Yun JE; Lee SY; Klein AP; Jee SH
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):359-64. PubMed ID: 18268120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk and genetic factors in pancreatic cancer.
    Gullo L; Lowenfels AB; Maisonneuve P
    Ital J Gastroenterol Hepatol; 1998 Dec; 30(6):587-92. PubMed ID: 10076778
    [No Abstract]   [Full Text] [Related]  

  • 10. Body mass index in the evaluation of thyroid cancer risk.
    Mijović T; How J; Pakdaman M; Rochon L; Gologan O; Hier MP; Black MJ; Young J; Tamilia M; Payne RJ
    Thyroid; 2009 May; 19(5):467-72. PubMed ID: 19415996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiology and clinical aspects of pancreatic cancer].
    Berndt H
    Z Arztl Fortbild (Jena); 1992 Jul; 86(13):643-8. PubMed ID: 1642016
    [No Abstract]   [Full Text] [Related]  

  • 12. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
    Duell EJ; Casella DP; Burk RD; Kelsey KT; Holly EA
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):726-31. PubMed ID: 16614115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic cancer: a review of the evidence on causation.
    Hart AR; Kennedy H; Harvey I
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):275-82. PubMed ID: 18328435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index and risk of diabetes mellitus in the Asia-Pacific region.
    ; Ni Mhurchu C; Parag V; Nakamura M; Patel A; Rodgers A; Lam TH
    Asia Pac J Clin Nutr; 2006; 15(2):127-33. PubMed ID: 16672195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pooled analysis of second primary pancreatic cancer.
    Shen M; Boffetta P; Olsen JH; Andersen A; Hemminki K; Pukkala E; Tracey E; Brewster DH; McBride ML; Pompe-Kirn V; Kliewer EV; Tonita JM; Chia KS; Martos C; Jonasson JG; Colin D; Scélo G; Brennan P
    Am J Epidemiol; 2006 Mar; 163(6):502-11. PubMed ID: 16421239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and cancer.
    Brawer R; Brisbon N; Plumb J
    Prim Care; 2009 Sep; 36(3):509-31. PubMed ID: 19616153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and risk factors for pancreatic cancer.
    Lowenfels AB; Maisonneuve P
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):197-209. PubMed ID: 16549324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan--the JPHC study.
    Luo J; Iwasaki M; Inoue M; Sasazuki S; Otani T; Ye W; Tsugane S;
    Cancer Causes Control; 2007 Aug; 18(6):603-12. PubMed ID: 17401636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthropometry and pancreatic cancer risk: an illustration of the importance of microscopic verification.
    Verhage BA; Schouten LJ; Goldbohm RA; van den Brandt PA
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1449-54. PubMed ID: 17585056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.
    Giovannucci E; Michaud D
    Gastroenterology; 2007 May; 132(6):2208-25. PubMed ID: 17498513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.